MARKET

GENE

GENE

Genetic Technologies
NASDAQ
2.890
+0.080
+2.85%
After Hours: 2.890 0 0.00% 16:01 03/28 EDT
OPEN
2.800
PREV CLOSE
2.810
HIGH
2.940
LOW
2.800
VOLUME
16.07K
TURNOVER
0
52 WEEK HIGH
6.00
52 WEEK LOW
1.800
MARKET CAP
11.12M
P/E (TTM)
-2.4192
1D
5D
1M
3M
1Y
5Y
Cannabis Stock Gainers And Losers From March 27, 2024
Canopy Gwth shares closed up 30.57% at $9.55. Green Growth Brands (OTC:GGBXF) shares closed down 99.00%. Canopy shares were the biggest gainers in the sector. Canopy and other cannabis companies closed up in the last day.
Benzinga · 1d ago
Cannabis Stock Movers For March 26, 2024
Shares of Auxly Cannabis Group (OTC:CBWTF) closed up 72.31% at $0.04. Village Farms Intl shares closed up 19.81%. Canopy Gwth (NASDAQ:CGC) shares up 18.71%. Beleave shares closed down 99.96%.
Benzinga · 2d ago
Genetic Technologies Boosts Capital with Radium Loan
TipRanks · 2d ago
Weekly Report: what happened at GENE last week (0318-0322)?
Weekly Report · 3d ago
Genetic Technologies Named Kathryn Andrews As New CFO
Benzinga · 3d ago
Cannabis Stock Gainers And Losers From March 22, 2024
Canopy Gwth shares closed up 52.19% at $6.94. Aurora Cannabis and Tilray Brands were among the biggest gainers in the cannabis sector. Canopy shares are up 22.14% in the past day. Belgravia Hartford Cap shares closed down 48.61% in a day.
Benzinga · 6d ago
Genetic Technologies Says "GTG To Develop Worlds Most Advanced Comprehensive Risk Test Revolutionizing Personalized Healthcare"; Shares Move Higher
Benzinga · 6d ago
Genetic Technologies Unveils Revolutionary Risk Test
TipRanks · 6d ago
More
About GENE
Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its geneType and EasyDNA brands. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company operates through three segments: EasyDNA, AffinityDNA, and GeneType / Corporate. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses. GeneType / Corporate segment relates to geneType branded test sales and expenses, including corporate charges. The GeneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and mor

Webull offers Genetic Technologies Limited (ADR) stock information, including NASDAQ: GENE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GENE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GENE stock methods without spending real money on the virtual paper trading platform.